Clinical Trials Directory

Trials / Completed

CompletedNCT00585637

Vitamin D for Chemoprevention

Defining Optimal Doses of Vitamin D for Chemoprevention in Blacks.

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
328 (actual)
Sponsor
Dana-Farber Cancer Institute · Academic / Other
Sex
All
Age
30 Years – 80 Years
Healthy volunteers
Accepted

Summary

This study will help us know the effects of Vitamin D pills in Blacks. The results of this study may be the first step in creating ways to prevent the risks of colon and prostate cancer. It will also help us develop ways to reduce colon cancer and prostate cancer among Blacks. This study will find out if Vitamin D pills can increase Vitamin D to healthy levels in our bodies.

Detailed description

* Participants will be asked to answer some questions about their diet, exercise and health. In addition, participants blood pressure will be taken. These assessments will occur at baseline, 3- and 6-month appointments. At baseline only, we will measure skin tone with a tool called the Photovolt 577. * A small blood sample will be taken to see how much Vitamin D is the body and will also look at levels of other markers of disease such as proteins, hormones, and genes. * Participants will take a vitamin pill every day for three months and be randomly assigned to one of four different types of pills. * Participants will be called or visited at least every two weeks. They will be asked questions to determine if they have any side effects associated with high levels of Vitamin D. * At the beginning of the second and third months, participants will be provided with more pills. At the end of the third month, another blood sample will be taken. Three months after that, the final blood sample will be taken.

Conditions

Interventions

TypeNameDescription
DRUGVitamin DTaken orally every day for three months
DIETARY_SUPPLEMENTPlaceboPlacebo pill taken once daily for 3 month

Timeline

Start date
2007-10-01
Primary completion
2010-10-01
Completion
2013-12-01
First posted
2008-01-03
Last updated
2015-04-01
Results posted
2015-04-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00585637. Inclusion in this directory is not an endorsement.